Capital Fund Management (CFM)
CLB icon

Capital Fund Management (CFM)’s Core Laboratories CLB Stock Holding History

Capital Fund Management (CFM)’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,600
Closed -$286K – 1608
2019
Q4 		$286K Sell
7,600
-76,700
-91% -$3.45M ﹤0.01% 1620
2019
Q3 		$3.93M Sell
84,300
-75,200
-47% -$3.5M 0.04% 560
2019
Q2 		$8.34M Sell
159,500
-1,100
-0.7% -$64.5K 0.08% 356
2019
Q1 		$11.1M Buy
+160,600
New +$10.8M 0.1% 273
2015
Q3 		– Sell
-3,800
Closed -$433K – 1440
2015
Q2 		$433K Sell
3,800
-2,700
-42% -$327K 0.01% 1130
2015
Q1 		$679K Buy
+6,500
New +$693K 0.01% 924
2014
Q4 		– Sell
-1,500
Closed -$220K – 1599
2014
Q3 		$220K Sell
1,500
-500
-25% -$77.2K ﹤0.01% 1427
2014
Q2 		$334K Buy
+2,000
New +$356K ﹤0.01% 1387

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital Fund Management (CFM)'s CLB Position: Q4 2020 in Review

Capital Fund Management (CFM) sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 39,144 shares — an estimated $597K sold.

Capital Fund Management (CFM) first reported a position in CLB in Q2 2013 and held it in 17 quarters. The position peaked at $21.9M in Q2 2014. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

  • Capital Fund Management (CFM) reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 39,144 Core Laboratories shares in Q4 2020, an estimated $597K.
  • Capital Fund Management (CFM) first reported a position in Core Laboratories in Q2 2013 and held it in 17 quarters.
  • Capital Fund Management (CFM)'s Core Laboratories position peaked at $21.9M in Q2 2014.
  • 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2020, filed 12 Feb 2021.